ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ)
$282.85 -6.54 (-2.2599%)
Analysed ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) News Sources
Alnylam Pharmaceuticals (ALNY) Valuation Check As US$2b AI RNAi Collaboration With Inceptive Nucleics Gains Attention
05-06-2026
yahoo.com
Why Is Sarepta Therapeutics (SRPT) Down 19.9% Since Last Earnings Report?
05-06-2026
yahoo.com
Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
08-06-2026
yahoo.com
Bloom Energy, Astera Labs, Alnylam, Reddit Could Be Among Next Adds to S&P 500
08-06-2026
yahoo.com
Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts
09-06-2026
marketbeat.com
GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region
10-06-2026
yahoo.com
Junevity Partners with Sunrise BioVentures as Advisors to Accelerate siRNA Therapeutic Development
10-06-2026
yahoo.com
Alnylam to Host Tenth "RNAi Roundtable" Webcast Series
12-06-2026
yahoo.com
Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?
12-06-2026
yahoo.com
Alnylam Taps Generative AI And Nordic Expansion As Market Lags Targets
14-06-2026
yahoo.com
What is the current price of ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ)?
The current price of ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) is $282.85.
ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) since the previous trading day is $-6.54.
ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) since the previous trading day is -2.2599%.
What is the most recent average sentiment score for ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ)?
The most recent average sentiment score for ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ)?
The most recent sentiment for ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) is .
SEC-8K** Filing Available For ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.